2160.T
Price:
$2371
Market Cap:
$131.82B
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial phase II and pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase II clinical trial for the treatment of liver fibrosis; and F573 that is i...[Read more]
Industry
Biotechnology
IPO Date
2007-08-31
Stock Exchange
JPX
Ticker
2160.T
According to GNI Group Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -637.37. This represents a change of 1.10% compared to the average of -52.94 of the last 4 quarters.
The mean historical PE Ratio of GNI Group Ltd. over the last ten years is 37.23. The current -637.37 PE Ratio has changed -171306.90% with respect to the historical average. Over the past ten years (40 quarters), 2160.T's PE Ratio was at its highest in in the March 2022 quarter at 228.64. The PE Ratio was at its lowest in in the June 2017 quarter at -441.01.
Average
37.23
Median
63.80
Minimum
-424.50
Maximum
215.33
Discovering the peaks and valleys of GNI Group Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 943.19%
Maximum Annual PE Ratio = 215.33
Minimum Annual Increase = -150.73%
Minimum Annual PE Ratio = -424.50
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 174.17 | 943.19% |
| 2023 | 16.70 | -90.18% |
| 2022 | 170.08 | 160.94% |
| 2021 | 65.18 | 4.42% |
| 2020 | 62.42 | -64.54% |
| 2019 | 176.04 | -18.25% |
| 2018 | 215.33 | -150.73% |
| 2017 | -424.50 | 778.21% |
| 2016 | -48.34 | 38.89% |
| 2015 | -34.80 | -68.41% |
The current PE Ratio of GNI Group Ltd. (2160.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
120.31
5-year avg
97.71
10-year avg
37.23
GNI Group Ltd.’s PE Ratio is less than Takara Bio Inc. (160.35), less than Kaken Pharmaceutical Co., Ltd. (234.71), less than Towa Pharmaceutical Co., Ltd. (8.66), less than Tsuruha Holdings Inc. (23.98), less than BML, Inc. (23.00), less than PHC Holdings Corporation (23.65), less than Mani, Inc. (26.79), less than Nxera Pharma Co., Ltd. (-12.46), less than Kissei Pharmaceutical Co., Ltd. (13.27), less than NIHON CHOUZAI Co.,Ltd. (46.16),
| Company | PE Ratio | Market cap |
|---|---|---|
| 160.35 | $92.84B | |
| 234.71 | $152.80B | |
| 8.66 | $178.69B | |
| 23.98 | $135.94B | |
| 23.00 | $146.81B | |
| 23.65 | $137.77B | |
| 26.79 | $143.81B | |
| -12.46 | $76.56B | |
| 13.27 | $192.34B | |
| 46.16 | $117.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GNI Group Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GNI Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is GNI Group Ltd.'s PE Ratio?
How is the PE Ratio calculated for GNI Group Ltd. (2160.T)?
What is the highest PE Ratio for GNI Group Ltd. (2160.T)?
What is the 3-year average PE Ratio for GNI Group Ltd. (2160.T)?
What is the 5-year average PE Ratio for GNI Group Ltd. (2160.T)?
How does the current PE Ratio for GNI Group Ltd. (2160.T) compare to its historical average?